Isoniazid in the treatment of chronic lupus erythematosus.

@article{Appel1953IsoniazidIT,
  title={Isoniazid in the treatment of chronic lupus erythematosus.},
  author={B. Appel and G. R. Baler and E. Dougherty},
  journal={A.M.A. archives of dermatology and syphilology},
  year={1953},
  volume={68 4},
  pages={
          417-20
        }
}
  • B. Appel, G. R. Baler, E. Dougherty
  • Published 1953
  • Medicine
  • A.M.A. archives of dermatology and syphilology
  • CHRONIC lupus erythematosus is notoriously resistant to treatment. Until 1951, bismuth, gold, and arsenic were the principal systemic agents; second choices were suramin sodium (Naphuride), 1 quinine, crude liver extract, and vitamin E; third choice was local destruction, usually with carbon dioxide. In 1951, quinacrine (Mepacrine, Atabrine) was reported by Page 2 to have produced excellent results, and personal reports to us by several dermatologists indicate an increasing confirmation of good… CONTINUE READING
    2 Citations

    References

    SHOWING 1-7 OF 7 REFERENCES
    Studies on the activity of hydrazine derivatives of isonicotinic acid in the experimental tuberculosis of mice.
    • E. Grunberg, R. Schnitzer
    • Medicine
    • Quarterly bulletin of Sea View Hospital. New York. Sea View Hospital, Staten Island. Clinical Society
    • 1952
    • 45
    Treatment of lupus erythematosus with mepacrine.
    • 242
    Modern Dermatology and Syphilology
    • 149
    Diseases of the Skin
    • 934